Format

Send to

Choose Destination
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):455-466. doi: 10.1038/nrgastro.2017.71. Epub 2017 Jun 21.

Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.

Author information

1
Department of Medicine, University of Massachusetts Medical School, LRB208, 364 Plantation Street, Worcester, Massachusetts 01605, USA.

Abstract

Extracellular vesicles (EVs) are membranous vesicles originating from different cells in the liver. The pathophysiological role of EVs is increasingly recognized in liver diseases, including alcoholic liver disease, NAFLD, viral hepatitis and hepatocellular carcinoma. EVs, via their cargo, can provide communication between different cell types in the liver and between organs. EVs are explored as biomarkers of disease and could also represent therapeutic targets and vehicles for treatment delivery. Here, we review advances in understanding the role of EVs in liver diseases and discuss their utility in biomarker discovery and therapeutics.

PMID:
28634412
PMCID:
PMC6380505
DOI:
10.1038/nrgastro.2017.71
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center